USPH

USPH

USD

U.S. Physical Therapy Inc. Common Stock

$70.530+1.050 (1.511%)

Precio en Tiempo Real

Healthcare
Medical Care Facilities
Estados Unidos

Gráfico de Precios

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$69.480

Máximo

$73.680

Mínimo

$69.040

Volumen

0.01M

Fundamentos de la Empresa

Capitalización de Mercado

1.1B

Industria

Medical Care Facilities

País

United States

Estadísticas de Negociación

Volumen Promedio

0.12M

Bolsa

NYQ

Moneda

USD

Rango de 52 Semanas

Mínimo $62.77Actual $70.530Máximo $108.14

Informe de Análisis de IA

Última actualización: 26 abr 2025
Generado por IAFuente de Datos: Yahoo Finance, Bloomberg, SEC

USPH (U.S. Physical Therapy Inc. Common Stock): Analyzing Recent Moves & What Might Come Next

Stock Symbol: USPH Generate Date: 2025-04-26 22:52:53

Let's break down what's been happening with U.S. Physical Therapy stock lately, looking at the news, how the price has moved, and what some predictions are saying.

Recent News Buzz

What's the latest chatter around USPH? Well, there are a couple of recent announcements.

First off, the company just set the date for its first-quarter 2025 earnings report and conference call. This is pretty standard stuff – companies have to tell everyone how they did financially. It's not good or bad news on its own, but it means we'll get a clearer picture of the company's health soon, which could definitely move the stock.

More interestingly, an analyst over at JMP Securities recently reiterated their "Market Outperform" rating on USPH. Think of this as an analyst saying, "Hey, I think this stock is going to do better than the overall market." Not only that, they stuck with a price target of $113. That's a pretty strong vote of confidence from a professional observer, especially when you look at where the stock price is right now.

So, the news vibe is a bit mixed – one routine announcement, but one clear positive signal from an analyst who thinks the stock has significant room to grow.

Price Check: What's the Stock Been Doing?

Now, let's look at the stock's actual performance over the past few months. It's been a bit of a rough ride. Back in late January, the stock was trading up around $89 to $91. From there, it generally trended downwards, sometimes quite sharply. It hit its 52-week low of $62.77 just recently, in early April.

Since hitting that low, the price has bounced back a bit. The last recorded price was $70.53. So, while it's still way down from where it was earlier in the year and far below that $113 analyst target, it has shown some signs of stabilizing and recovering slightly from its lowest point. The trading volume has been a bit up and down, sometimes seeing spikes on big price moves.

What about the super short-term? An AI prediction model suggests the price might stay pretty flat or tick up just slightly over the next couple of days (predictions of +0.0%, +0.13%, +0.11%). This doesn't point to any immediate big moves, just maybe a bit of gentle upward drift or sideways trading right now.

Putting It Together: Outlook & Ideas

Okay, let's connect the dots. You've got an analyst who's quite bullish, seeing the stock potentially going to $113, while the stock itself has been in a significant decline but recently found a floor around the low $60s and bounced into the low $70s. The AI sees minimal movement right now.

Based on this mix, the situation might lean towards a potential 'buy' or 'accumulate' window for investors who believe the analyst's long-term view is realistic. The stock is trading far below its previous highs and the analyst's target, and it's just bounced off its 52-week low.

If someone were considering getting involved, a potential entry area could be around the current price ($70.53) or perhaps waiting to see if it dips back slightly towards that recent low point in the mid-$60s. The idea here is potentially buying low relative to where the analyst thinks it's headed.

For managing risk, setting a stop-loss just below that recent 52-week low, maybe around $63.48 (as suggested by some data), could be a sensible move. This level is below where the stock recently bounced, so if it falls below that, it could signal the downtrend is resuming. On the flip side, if the stock starts climbing, a potential take-profit level for a shorter-term trade might be around $75.84, which is indicated as a potential target in some analysis.

Company Context

Just a quick reminder about the company itself: U.S. Physical Therapy runs physical therapy clinics and also provides injury prevention services to businesses. They're in the Healthcare sector, specifically Medical Care Facilities. Knowing this helps understand that things affecting healthcare demand or workplace safety trends could impact their business. The company has a market cap of around $1 billion and a P/E ratio around 24, which gives you a sense of its size and how expensive it is relative to its earnings. It's important to remember how much the stock has fallen from its 52-week high of $108.14 to the recent low of $62.77 – that's a big drop, highlighting the volatility and risk involved.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock investing involves risk, and you could lose money. Always conduct your own thorough research or consult with a qualified financial advisor before making any investment decisions.

Noticias Relacionadas

BusinessWire

U.S. Physical Therapy, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call Dates

U.S. Physical Therapy, Inc. (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the

Ver más
U.S. Physical Therapy, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call Dates
Analyst Upgrades

JMP Securities Reiterates Market Outperform on US Physical Therapy, Maintains $113 Price Target

JMP Securities analyst Constantine Davides reiterates US Physical Therapy with a Market Outperform and maintains $113 price target.

Ver más
JMP Securities Reiterates Market Outperform on US Physical Therapy, Maintains $113 Price Target

Predicción de IABeta

Recomendación de IA

Alcista

Actualizado el: 28 abr 2025, 02:27

BajistaNeutralAlcista

65.4% Confianza

Riesgo y Negociación

Nivel de Riesgo3/5
Riesgo Medio
Adecuado Para
Moderado
Guía de Negociación

Punto de Entrada

$70.02

Toma de Ganancias

$75.85

Stop Loss

$63.48

Factores Clave

PDI 13.6 está por encima de MDI 10.6 con ADX 8.2, lo que sugiere una tendencia alcista
El precio actual está extremadamente cerca del nivel de soporte ($70.20), lo que sugiere una fuerte oportunidad de compra
El volumen de operaciones es 5.6 veces el promedio (1,637), lo que indica una presión de compra extremadamente fuerte
El MACD 0.1223 está por encima de la línea de señal 0.0997, lo que indica un cruce alcista

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.